Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 86,022Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Sanofi Winthrop Industrie

02 2Biosimilar Collaborations Ireland Limited

03 6NOVO NORDISK A/S

04 36Novo Nordisk A/S

05 11Novo Nordisk Pharma Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Insulin, Aspart

Brand Name : Insulin Aspart Sanofi

Dosage Form : Injectable Solution

Dosage Strength : 100E/ml

Packaging :

Approval Date : 21/04/2021

Application Number : 20200727000046

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Insulin, Aspart

Brand Name : Insulin Aspart Sanofi

Dosage Form : Solution For Injection

Dosage Strength : 100E/ml

Packaging :

Approval Date : 25/06/2020

Application Number : 20190604000057

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Insulin, Aspart

Brand Name : Insulin Aspart Sanofi

Dosage Form : Solution For Injection

Dosage Strength : 100E/ml

Packaging :

Approval Date : 25/06/2020

Application Number : 20190604000064

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Deregistered

Registration Country : Sweden

Insulin Aspart (Soluble); Insulin Aspart Protamine

Brand Name : Truvelog Mix 30

Dosage Form : Suspension For Injection

Dosage Strength : 100E/ml

Packaging :

Approval Date : 25/04/2022

Application Number : 20210429000121

Regulatory Info : Deregistered

Registration Country : Sweden

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Deregistered

Registration Country : Sweden

Insulin Aspart (Soluble); Insulin Aspart Protamine

Brand Name : Truvelog Mix 30

Dosage Form : Injectable Solution

Dosage Strength : 100E/ml

Packaging :

Approval Date : 25/04/2022

Application Number : 20210429000114

Regulatory Info : Deregistered

Registration Country : Sweden

Sanofi Company Banner

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Novorapid

Brand Name : Novorapidfill

Dosage Form : Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : 5 cartridges SC 300 IU 3 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Novorapid

Brand Name : Novorapid Flexpen

Dosage Form : Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : 5 cartridges SC in pens preriemp 3 ml 100 U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Novorapid

Brand Name : Novomix

Dosage Form : Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXPEN 5 cartridges SC in pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Novorapid

Brand Name : Novomix

Dosage Form : Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXPEN 5 cartridges SC in pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

Fall Technical Meeting
Not Confirmed
arrow
arrow
Fall Technical Meeting
Not Confirmed

Novorapid

Brand Name : Novomix

Dosage Form : Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXPEN 5 cartridges SC in pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank